Serum soluble fms-like tyrosine kinase-1 in the three trimesters of pregnancy: effects of maternal characteristics and medical history

Competing risks model in screening for preeclampsia by maternal characteristics and medical history

(2015) David Wright et al.   AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY

Competing Risks Model in Screening for Preeclampsia by Serum Placental Growth Factor and Soluble fms-Like Tyrosine Kinase-1 at 30-33 Weeks' Gestation

(2014) Jonathan Lai et al.   FETAL DIAGNOSIS AND THERAPY

Angiogenic Factors and the Risk of Adverse Outcomes in Women With Suspected Preeclampsia

(2012) Sarosh Rana et al.   CIRCULATION

Birthweight with Gestation and Maternal Characteristics in Live Births and Stillbirths

(2012) Leona C.Y. Poon et al.   FETAL DIAGNOSIS AND THERAPY

Competing Risks Model in Early Screening for Preeclampsia by Biophysical and Biochemical Markers

(2012) Ranjit Akolekar et al.   FETAL DIAGNOSIS AND THERAPY

A Competing Risks Model in Early Screening for Preeclampsia

(2012) David Wright et al.   FETAL DIAGNOSIS AND THERAPY

Maternal plasma concentrations of angiogenic/anti-angiogenic factors are of prognostic value in patients presenting to the obstetrical triage area with the suspicion of preeclampsia

(2012) Tinnakorn Chaiworapongsa et al.   Journal of Maternal-Fetal & Neonatal Medicine

The sFlt-1/PlGF ratio in different types of hypertensive pregnancy disorders and its prognostic potential in preeclamptic patients

(2011) Stefan Verlohren et al.   AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY